Name: What conversation do you have with your patients with regard to the safety of topical ruxolitinib?
Uploaded: 2022-07-27T00:00:00.000Z
Description: What conversation do you have with your patients with regard to the safety of topical ruxolitinib?

Welcome to Dermbits! Watch short videos of KOLs answering your questions

thumbnail_dermbits-colorful.png

dermbits-colorful.png

Dermbits

What conversation do you have with your patients with regard to the safety of topical ruxolitinib?

Atopic Dermatitis

So when I'm prescribing or thinking of prescribing ruxolitnib to my patients I basically forewarn them about the black box warning or the package insert that they will see which talks about malignancy, mace events and things of that nature. And I sort of put this in context that because of ruxolitinib belonging to a class of other oral jack inhibitors which did see some signals with regards to those side effects the FDA had to give it to it. And then I sort of even joke and say that, you know what, you will see the side effects only if you eat ruxolitinib which obviously patients are not doing. They're applying it on the skin. So when it comes to applying it on the skin there is not much in terms of systemic absorption. So when I put things in that context patients don't get worried about reading the package insert or the black box warning by themselves and they are aware of that being in the package insert and they've been assured that that is not an issue and.

What conversation do you have with your patients with regard to the safety of topical ruxolitinib?

Related CME